Is Pitobrutinib available in China?

Pitobrutinib, a revolutionary drug, brings hope to patients with relapsed or refractory mantle cell lymphoma. This drug is a kinase inhibitor that can precisely act on specific targets in lymphoma cells, blocking the growth and spread of cancer cells by inhibiting kinase activity. Its unique mechanism of action enables pitobrutinib to exhibit excellent efficacy during treatment.

In clinical trials, pitobrutinib performed impressively. Pitobrutinib exhibits significant antitumor activity in patients whose disease has not been controlled despite multiple treatment options. It can not only reduce the tumor burden in patients, but can even enable some patients to achieve complete remission, that is, there is no sign of cancer in the body. Such efficacy undoubtedly brings great hope to patients.

In addition, pitobrutinib also demonstrated good safety during treatment. Compared with traditional chemotherapy drugs, it has relatively fewer side effects and patients can tolerate the treatment better. This means that patients can maintain a relatively good quality of life and reduce the pain caused by the disease while receiving treatment.

The development and application of pitobrutinib not only reflects the rapid progress of medical technology, but also demonstrates mankind's firm determination to defeat cancer. With the widespread use of this drug, I believe that more lymphoma patients will benefit from it in the future and regain health and hope. Pitobrutinib has undoubtedly become a shining pearl in the field of lymphoma treatment.

Currently, Pitobrutinib is not available in the domestic market. Therefore, patients who need this drug can only choose to purchase it abroad or contact overseas professional medical consulting companies. It is reported that there are two types of pitobrutinib overseas: the original version and the generic version. Among them, the original version of 50mg*30 tablets sold in the United States is priced at about 100,000 yuan, while the price of the generic version in Laos is about 4,500 yuan. If you want to learn more about pitobrutinib, it is recommended to consult a regular overseas medical consulting agency.

xa0

Reference: https://www.drugs.com/pirtobrutinib.html